Cargando…

Change in Urinary Myoinositol/Citrate Ratio Associates with Progressive Loss of Renal Function in ADPKD Patients

INTRODUCTION: In autosomal dominant polycystic kidney disease (ADPKD) patients, predicting renal disease progression is important to make a prognosis and to support the clinical decision whether to initiate renoprotective therapy. Conventional markers all have their limitations. Metabolic profiling...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dekker, Shosha E.I., Verhoeven, Aswin, Frey, Daria, Soonawala, Darius, Peters, Dorien J.M., Mayboroda, Oleg A., de Fijter, Johan W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2022
Materias:	Patient-Oriented, Translational Research: Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393825/ https://www.ncbi.nlm.nih.gov/pubmed/35613556 http://dx.doi.org/10.1159/000524851

Ejemplares similares

Urinary metabolites associate with the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease
por: Dekker, Shosha E. I., et al.
Publicado: (2020)

Urinary Tissue Inhibitor of Metalloproteinases-2 and Insulin-Like Growth Factor–Binding Protein 7 Do Not Correlate With Disease Severity in ADPKD Patients
por: Dekker, Shosha E.I., et al.
Publicado: (2019)

Simultaneous analyses of urinary eicosanoids and related mediators identified tetranor-prostaglandin E metabolite as a novel biomarker of diabetic nephropathy
por: Morita, Yoshifumi, et al.
Publicado: (2021)

Extended-Release Calcifediol Effectively Raises Serum Total 25-Hydroxyvitamin D Even in Overweight Nondialysis Chronic Kidney Disease Patients with Secondary Hyperparathyroidism
por: Bishop, Charles W., et al.
Publicado: (2022)

Initial eGFR Changes with Ertugliflozin and Associations with Clinical Parameters: Analyses from the VERTIS CV Trial
por: Cherney, David Z.I., et al.
Publicado: (2022)

Desidustat in Anemia due to Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-D)
por: Gang, Sishir, et al.
Publicado: (2022)

Trends in Adherence to Recommended Physical Activity and Its Association with Mortality and Disease Progression among US Adults with Chronic Kidney Disease
por: Qu, Xiaolin, et al.
Publicado: (2022)

Overall Adverse Event Profile of Vadadustat versus Darbepoetin Alfa for the Treatment of Anemia Associated with Chronic Kidney Disease in Phase 3 Trials
por: Agarwal, Rajiv, et al.
Publicado: (2023)

Comparison between the Effects of Allopurinol and Febuxostat on the Survival of Patients on Maintenance Hemodialysis
por: Kang, Seok Hui, et al.
Publicado: (2023)

Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D)
por: Macdougall, Iain C., et al.
Publicado: (2023)

Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors Secondary to Hyperkalemia Translates into Higher Cardiorenal Outcomes
por: An, Jaejin, et al.
Publicado: (2023)

Interleukin-6-to-Albumin Ratio as a Superior Predictor of Mortality in End-Stage Kidney Disease Patients
por: Li, Xiejia, et al.
Publicado: (2023)

Association of Self-Reported Nighttime Sleep Duration with Chronic Kidney Disease: China Health and Retirement Longitudinal Study
por: Jiang, Bingxin, et al.
Publicado: (2023)

Association of the novel cardiovascular risk factors paraoxonase 1 and cystatin C in type 2 diabetes
por: Connelly, Philip W., et al.
Publicado: (2009)

Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a)
por: Deshmukh, Harshal A., et al.
Publicado: (2012)

Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity
por: Rubinow, Katya B., et al.
Publicado: (2012)

Intake levels of dietary long-chain PUFAs modify the association between genetic variation in FADS and LDL-C
por: Hellstrand, S., et al.
Publicado: (2012)

Plasma apolipoprotein O level increased in the patients with acute coronary syndrome
por: Yu, Bi-lian, et al.
Publicado: (2012)

Effects of Therapeutic Lifestyle Change diets high and low in dietary fish-derived FAs on lipoprotein metabolism in middle-aged and elderly subjects
por: Ooi, Esther M. M., et al.
Publicado: (2012)

Effects of prescription niacin and omega-3 fatty acids on lipids and vascular function in metabolic syndrome: a randomized controlled trial
por: Shearer, Gregory C., et al.
Publicado: (2012)

Action myoclonus-renal failure syndrome: diagnostic applications of activity-based probes and lipid analysis
por: Gaspar, Paulo, et al.
Publicado: (2014)

New insights regarding tissue Se and Hg interactions on oxidative stress from plasma IsoP and IsoF measures in the Canadian Inuit population
por: Alkazemi, Dalal, et al.
Publicado: (2013)

Statin action favors normalization of the plasma lipidome in the atherogenic mixed dyslipidemia of MetS: potential relevance to statin-associated dysglycemia
por: Meikle, Peter J., et al.
Publicado: (2015)

Circulating microparticles carry oxidation-specific epitopes and are recognized by natural IgM antibodies(1)
por: Tsiantoulas, Dimitrios, et al.
Publicado: (2015)

The implication of cigarette smoking and cessation on macrophage cholesterol efflux in coronary artery disease patients
por: Song, Wei, et al.
Publicado: (2015)

Genetic loci associated with circulating levels of very long-chain saturated fatty acids
por: Lemaitre, Rozenn N., et al.
Publicado: (2015)

Enhancement of lipid peroxidation and its amelioration by vitamin E in a subject with mutations in the SBP2 gene
por: Saito, Yoshiro, et al.
Publicado: (2015)

Thyroid hormone reduces PCSK9 and stimulates bile acid synthesis in humans
por: Bonde, Ylva, et al.
Publicado: (2014)

Adiposity significantly modifies genetic risk for dyslipidemia
por: Cole, Christopher B., et al.
Publicado: (2014)

Identification of a novel mutation in the PNLIP gene in two brothers with congenital pancreatic lipase deficiency
por: Behar, Doron M., et al.
Publicado: (2014)

Differential effects of EPA versus DHA on postprandial vascular function and the plasma oxylipin profile in men
por: McManus, Seán, et al.
Publicado: (2016)

The relationship between non-HDL cholesterol and macrophage phenotypes in human adipose tissue
por: Poledne, Rudolf, et al.
Publicado: (2016)

Association of peripheral differential leukocyte counts with dyslipidemia risk in Chinese patients with hypertension: insight from the China Stroke Primary Prevention Trial
por: Liu, Yanhong, et al.
Publicado: (2017)

Defective cholesterol metabolism in amyotrophic lateral sclerosis
por: Abdel-Khalik, Jonas, et al.
Publicado: (2017)

Normal human adipose tissue functions and differentiation in patients with biallelic LPIN1 inactivating mutations
por: Pelosi, Michele, et al.
Publicado: (2017)

Diabetes adversely affects phospholipid profiles in human carotid artery endarterectomy plaques
por: Zayed, Mohamed A., et al.
Publicado: (2018)

Use of next-generation sequencing to detect LDLR gene copy number variation in familial hypercholesterolemia
por: Iacocca, Michael A., et al.
Publicado: (2017)

Polygenic determinants in extremes of high-density lipoprotein cholesterol
por: Dron, Jacqueline S., et al.
Publicado: (2017)

Analysis of HETEs in human whole blood by chiral UHPLC-ECAPCI/HRMS
por: Mazaleuskaya, Liudmila L., et al.
Publicado: (2018)

Cerebral organoids derived from Sandhoff disease-induced pluripotent stem cells exhibit impaired neurodifferentiation
por: Allende, Maria L., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8mtvff934pef048blp2es8mdgj